DiaMedica Therapeutics Overview
DiaMedica Therapeutics Target Price
Analysts' 12-month price predictions for DMAC.
Get informed when a big investor buys or sells
+ FollowShare Price
$5.65
Average Target Price
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2024-10-07 | Truist FinancialBill Chappell | $10 |  77% upside |  |
| 2024-10-07 | H.C. WainwrightMatthew Caufield | $7 | 23.9% upside | |
| 2024-03-21 | Craig-HallumAlex Nowak | $8 | 41.6% upside | |